(2005). Bristol-Myers Squibb Case Study: Overcoming the threat from generic Antidiabetics. Marketline.
Cita Chicago Style (17a ed.)Bristol-Myers Squibb Case Study: Overcoming the Threat from Generic Antidiabetics. Marketline, 2005.
Cita MLA (8a ed.)Bristol-Myers Squibb Case Study: Overcoming the Threat from Generic Antidiabetics. Marketline, 2005.
Precaución: Estas citas no son 100% exactas.